Abstract
ObjectiveOnly 70–80% of patients with chronic inflammatory demyelinating polyneuropathy (CIDP) respond satisfactorily to the established first-line immunomodulatory treatments. Autologous haematopoietic stem cell transplantation (AHSCT) has been performed as a last...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have